Evidence map›Paper›PMID 41471262›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Therapeutic Evaluation of Rosmarinic Acid in a Rat Model Combining Hypertension, Diabetes, and Nephrolithiasis.

Anelise Felício Macarini, Mariana Zanovello, Anelize Dada, Rita de Cássia Vilhena da Silva, Rogério Corrêa, Priscila de Souza

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anelise Felício MacariniPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí 88302-901, Brazil.ORCID 0000-0003-0123-8005
Mariana ZanovelloPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí 88302-901, Brazil.
Anelize DadaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí 88302-901, Brazil.ORCID 0009-0009-6284-5993
Rita de Cássia Vilhena da SilvaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí 88302-901, Brazil.
Rogério CorrêaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí 88302-901, Brazil.ORCID 0000-0003-4907-4361
Priscila de SouzaPrograma de Pós-Graduação em Ciências Farmacêuticas, Universidade do Vale do Itajaí, Itajaí 88302-901, Brazil.ORCID 0000-0002-5251-5642

Funding

Coordenação de Aperfeicoamento de Pessoal de Nível Superior 001Fundação de Amparo à Pesquisa e Inovação do Estado de Santa Catarina 2021TR001783National Council for Scientific and Technological Development 001
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

blood pressurecomorbidity modelhyperglycemiaoxalate crystalspolyphenol

Identifiers

PMID41471262
PMCPMC12735802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.